4-154546211-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002669.4(PLRG1):āc.316G>Cā(p.Val106Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000134 in 1,570,722 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002669.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLRG1 | NM_002669.4 | c.316G>C | p.Val106Leu | missense_variant, splice_region_variant | 5/15 | ENST00000499023.7 | NP_002660.1 | |
PLRG1 | NM_001201564.2 | c.289G>C | p.Val97Leu | missense_variant, splice_region_variant | 5/15 | NP_001188493.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLRG1 | ENST00000499023.7 | c.316G>C | p.Val106Leu | missense_variant, splice_region_variant | 5/15 | 1 | NM_002669.4 | ENSP00000424417 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152106Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000758 AC: 19AN: 250802Hom.: 0 AF XY: 0.0000738 AC XY: 10AN XY: 135572
GnomAD4 exome AF: 0.0000134 AC: 19AN: 1418616Hom.: 0 Cov.: 24 AF XY: 0.0000155 AC XY: 11AN XY: 708626
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152106Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74288
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2023 | The c.316G>C (p.V106L) alteration is located in exon 5 (coding exon 5) of the PLRG1 gene. This alteration results from a G to C substitution at nucleotide position 316, causing the valine (V) at amino acid position 106 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at